-
Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapyOblak, Irena, 1967- ...The aim of the study was to analyze the prognostic significance of hemoglobin (Hb) concentration for loco-regional control and survival of patients with inoperable carcinoma of the oropharynx. ... Seventy patients with inoperable squamous cell carcinoma of the oropharynx were prospectively treated by concomitant regimen of conventional radiotherapy and chemotherapy with Mitomycin C and Bleomycin. The prognostic value of Iib concentratioa before the therapy (Hb-S) and at the end of the therapy (Hb-E), the difference between both (dHb), and the average Hb concentration (Hb-Av) were analyzed. Hbconcentration was falling significantly (median values, from 139 g/L to p < 0.0001) during the first three weeks of the therapy; after that, it reached a plateau. In the last week of therapy, a slight increase (p = 0.08) in Hb concentration was recorded. Significant correlation (p < 0.0001) was found between Hb-S and other Hb-related parameters. The median follow-up of the patients alive on close-out date was 5.7 years (range 4-10.5 years). Longer disease-free survival (DFS) and disease-specific survival (DSS) correlated with higher values of Hb-S (p = 0.0005, p = 0.008) and Hb-E (p = 0.02, p = 0.02), while the Hb-Av was predictive for DFS only (p = 0.004). The most significant difference between low- and high-Hb groups was calculated at cut-off concentrations of 122 (Hb-S), 116 (Hb-E), and 120 (Hb-Av) g/L. Only Hb-S was tested in multivariate model where its independent value for predicting both, DFS (p = 0.002; RR 3.6) and DSS (p = 0.01; RR 2.9), was confirmed. In our patients, Hb-S was proved to be an independent prognostic factor iu predicting DFS and DSS. We believe that the concentration of Hb >= 120 g/L should be maintained during radiotherapy course.Vir: Neoplasma. - ISSN 0028-2685 (Letn. 50, št. 6, 2003, str. 452-458)Vrsta gradiva - članek, sestavni delLeto - 2003Jezik - angleškiCOBISS.SI-ID - 17843161
Avtor
Oblak, Irena, 1967- |
Strojan, Primož |
Zakotnik, Branko |
Budihna, Marjan |
Šmid, Alojz, 1941-
Teme
Oropharyngeal Neoplasms |
Blood |
Radiotherapy |
Drug Therapy |
Hemoglobins |
Carcinoma, Squamous Cell |
Blood |
Radiotherapy |
Drug Therapy |
Bleomycin |
Therapeutic Use |
Antimetabolites, Antineoplastic |
Therapeutic Use |
Sex Factors |
Age Factors |
Survival Analysis |
Treatment Outcome |
Radiotherapy Dosage |
Prognosis |
Combined Modality Therapy |
Antimetaboliti antineoplastični |
Bleomicin |
Hemoglobini |
Karcinom ploščatocelični |
Orofaringealne novotvorbe |
Kombinirani način zdravljenja |
Preživetje, analiza |
Prognoza |
Radioterapija, doziranje |
Spolni faktorji |
Starostni faktorji |
Zdravljenje, izid
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Oblak, Irena, 1967- | 20052 |
Strojan, Primož | 14576 |
Zakotnik, Branko | 11747 |
Budihna, Marjan | 00702 |
Šmid, Alojz, 1941- | 02130 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.